How Assistance Works
Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience
-
1. Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
-
2. Transfer Prescription to AmeriPharma™
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
-
3. Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
-
4. Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma™ Specialty Care has secured $55 million in financial assistance for our patients.
-
5. Nursing Care Coordination If Needed
AmeriPharma™ puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
-
6. Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
![https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image.jpg](https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_mobile.jpg)
What Is Keytruda?
Keytruda is the trade name for pembrolizumab, an intravenous medication for treating several cancers among adults and children. Keytruda belongs to a family of immunotherapies called monoclonal antibodies. Physicians prescribe this medication in three ways:
- Monotherapy: As a standalone treatment
- Combination Therapy: As simultaneous treatment with other cancer medications
- Adjuvant Therapy: As a follow-on treatment to kill surviving cancer cells after a successful course with another medication
How Does Keytruda Work?
The human immune system has evolved to detect, kill and remove many types of cancer cells. However, some cancers can alter their chemical signatures, evade detection, and grow unmolested. Keytruda acts by blocking the pathway cancer cells use to remain undetected. Since the malignant cells are now exposed, the immune system is better able to target, destroy and remove them.
![https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg](https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block-image-2.jpeg)
What Conditions Does Keytruda Treat?
Keytruda has earned Food and Drug Administration approval for 19 types of cancer.
Breast Cancer
With inoperable breast cancers, physicians use Keytruda as a component in combination therapies. Where surgery is possible, doctors use this medication as a postoperative adjuvant treatment.
Skin Cancer
For the most serious type of skin cancer known as melanoma, physicians prescribe Keytruda as either a monotherapy or adjuvant. With cutaneous squamous cell carcinoma and Merkel cell carcinoma, doctors use Keytruda as a monotherapy.
Lung Cancer
With non-small cell lung cancer (NSCLC), doctors usually combine Keytruda with chemotherapy agents such as pemetrexed, carboplatin or paclitaxel. Keytruda may also be used as monotherapy in those patients who express a protein called PD-L1 on their cancer cells. It is also used as an adjuvant following resection of specific tumors.
Lymphoma
With blood cancers such as classical Hodgkin’s lymphoma or primary mediastinal large B-cell lymphoma, doctors use Keytruda as a monotherapy after other treatments have failed.
Organ Cancers
With cancers of the bladder, liver, colon, and rectum, physicians use Keytruda as a monotherapy. For stomach cancer, esophageal carcinoma, endometrial carcinoma, cervical cancer, and renal cell carcinoma, doctors use Keytruda as a monotherapy or in combination therapy, depending on individual patient circumstances.
Copay and Financial Assistance
AmeriPharma™ Specialty Care alleviates financial burdens for patients and their families
-
Advanced software locates funding sources to match you with top-dollar foundation programs
-
One of our copay assistance specialists will assist with the application process
-
Automatic updates will be sent to you and your physician on the status of the funding
![https://ameripharmaspecialty.com/wp-content/uploads/2024/02/Mask-Group-45-1.jpg](https://ameripharmaspecialty.com/wp-content/uploads/2024/02/Mask-Group-45-2.jpg)
Dosing Recommendations
Patients receive Keytruda doses as intravenous infusions in clinical settings. Infusion sessions usually last about 30 minutes. For adults, the recommended dose is 200 mg every 3 weeks or 400 mg every 6 weeks.
With pediatric cancers, the recommended dose is 2 mg for each kg of patient bodyweight. 200 mg is the maximum pediatric dose and the infusion is given every 3 weeks.
When patients receive other chemotherapy agents at the same appointment, Keytruda infusions should come first.
Time Limits
For all cancer types, Keytruda should be discontinued if the disease progresses or if treatment becomes toxic to the patient. Your doctor will decide the length of the treatment course as it may vary depending on several patient-specific factors. The maximum duration of treatment is 24 months for all cancer types except melanoma. Patients who take Keytruda for melanoma may continue treatment indefinitely.
Insurances Accepted
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Get Started in Minutes
Fill out your information and one of our specialists will call you ASAP.
How Much Can You Save?
Speak with a copay assistance specialist
(877) 778-0318By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices